[Diagnosis and treatment of ankylosing spondylitis (Bechterew disease)].
Rudwaleit
M
M
Medizinische Klinik I -- Rheumatologie, Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin. martin.rudwaleit@charite.de
Sieper
J
J
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D026741:Physical Therapy Modalities; D011859:Radiography; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012446:Sacroiliac Joint / Q000000981:diagnostic imaging / Q000473:pathology; D025241:Spondylarthritis / Q000175:diagnosis / Q000628:therapy; D013167:Spondylitis, Ankylosing / Q000175:diagnosis* / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept